Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-010985

Director sold 222,258 shares at an average $50.11 ($11,136,437)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2018-04-26 Sale −185,075 $50.11 $9,274,108 1,334,430 I
Bolzon Bradley J PhD Director 2018-04-26 Sale −5,430 $50.12 $272,152 39,152 I
Bolzon Bradley J PhD Director 2018-04-26 Sale −6,019 $50.12 $301,672 43,400 I
Bolzon Bradley J PhD Director 2018-04-26 Sale −14,086 $50.11 $705,849 101,559 I
Bolzon Bradley J PhD Director 2018-04-27 Sale −10,236 $50.02 $512,005 1,324,194 I
Bolzon Bradley J PhD Director 2018-04-27 Sale −300 $50.08 $15,024 38,852 I
Bolzon Bradley J PhD Director 2018-04-27 Sale −333 $50.01 $16,653 43,067 I
Bolzon Bradley J PhD Director 2018-04-27 Sale −779 $50.03 $38,973 100,780 I
Open-market sales · 222,258 sh · avg $50.11 · $11,136,437
Loading xslF345X03/doc4.xml…